OpenAlex
PricingAboutJobs
Log inGet started
Work

Subcutaneous semaglutide (NN9535) for the treatment of type 2 diabetes

HTML

Year: 2018
Type: review
Source: Expert Opinion on Biological Therapy
DOI: 10.1080/14712598.2018.1439014
Authors: Maka S Hedrington, Ana Tsiskarishvili, Stephen N Davis
Institution: University of Maryland, Baltimore
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: semaglutide, type 2 diabetes, GLP-1 receptor agonists, glycemic control, HbA1c, weight loss, beta-cell function, cardiovascular risk reduction, liraglutide, hypoglycemia risk, gastrointestinal adverse effects, diabetic retinopathy, long-acting injectables
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2792638657
FWCI: 0.192
Cites: 33
Cited by: 23
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security